PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Financial Results, Press Release
Announces Settlement Agreement Resolving PEDMARK Patent Litigation
Announces Clinical Research Collaboration With Tampa General Hospital Cancer Institute
Presents Real World Data Supporting the Integration and Clinical Use of Pedmark® in Treating Adults with Head & Neck Cancers
Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors
Announces Positive Topline Results from Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
Announces Full Debt Redemption
Announces Private Offering of Common Shares in Canada
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence
Submission Upload